These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7906091)

  • 1. Emerging options in the management of myocardial ischemia.
    Mehta JL
    Am J Cardiol; 1994 Jan; 73(3):18A-27A. PubMed ID: 7906091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
    Cohn PF
    Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angina pectoris and silent ischemia in the elderly: a management update.
    Lazar EJ; Lazar JM; Frishman W
    Geriatrics; 1992 Jul; 47(7):24-8, 35-6. PubMed ID: 1352266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianginal drug therapy for silent myocardial ischemia.
    Frishman WH; Teicher M
    Med Clin North Am; 1988 Jan; 72(1):185-96. PubMed ID: 3276984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal drug therapy for silent myocardial ischemia.
    Frishman WH; Teicher M
    Am Heart J; 1987 Jul; 114(1 Pt 1):140-7. PubMed ID: 2886034
    [No Abstract]   [Full Text] [Related]  

  • 9. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drugs acting on the heart in therapy of silent myocardial ischemia].
    Motz W; Scheler S; Strauer BE
    Internist (Berl); 1992 Oct; 33(10):695-700. PubMed ID: 1358855
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
    Kang JS; Goodman SG; Yan RT; Lopez-Sendon J; Pesant Y; Graham JJ; Fitchett D; Wong GC; Rose BF; Spencer FA; Yan AT;
    Am J Cardiol; 2013 Jul; 112(1):51-6. PubMed ID: 23582629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemia.
    Cohn PF
    Clin Ther; 1997; 19 Suppl A():74-91. PubMed ID: 9385506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of silent myocardial ischemia.
    Bleske BE; Shea MJ
    Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
    Deedwania PC; Cheitlin MD; Das SK; Pool PE; Singh JB; Pasternak RC
    Clin Cardiol; 1993 Aug; 16(8):599-602. PubMed ID: 8370191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of an ideal antianginal agent.
    Lazar EJ; Frishman WH
    Drugs; 1989; 38 Suppl 2():1-8. PubMed ID: 2575973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in drug therapy for coronary artery disease.
    Waters DD
    Can Med Assoc J; 1985 Mar; 132(6):625-7. PubMed ID: 2858259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.